tiprankstipranks
GENinCode UK Ltd. (GB:GENI)
LSE:GENI
Holding GB:GENI?
Track your performance easily

GENinCode UK Ltd. (GENI) Share Price & Analysis

3 Followers

GENI Stock Chart & Stats


Financials

Annual

GENI FAQ

What was GENinCode UK Ltd.’s price range in the past 12 months?
GENinCode UK Ltd. lowest share price was 3.10p and its highest was 10.00p in the past 12 months.
    What is GENinCode UK Ltd.’s market cap?
    GENinCode UK Ltd.’s market cap is £5.75M.
      When is GENinCode UK Ltd.’s upcoming earnings report date?
      GENinCode UK Ltd.’s upcoming earnings report date is Jun 10, 2025 which is in 142 days.
        How were GENinCode UK Ltd.’s earnings last quarter?
        GENinCode UK Ltd. released its earnings results on Sep 25, 2024. The company reported -0.014p earnings per share for the quarter, missing the consensus estimate of N/A by -0.014p.
          Is GENinCode UK Ltd. overvalued?
          According to Wall Street analysts GENinCode UK Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does GENinCode UK Ltd. pay dividends?
            GENinCode UK Ltd. does not currently pay dividends.
            What is GENinCode UK Ltd.’s EPS estimate?
            GENinCode UK Ltd.’s EPS estimate is -1.5.
              How many shares outstanding does GENinCode UK Ltd. have?
              GENinCode UK Ltd. has 176,964,430 shares outstanding.
                What happened to GENinCode UK Ltd.’s price movement after its last earnings report?
                GENinCode UK Ltd. reported an EPS of -0.014p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.704%.
                  Which hedge fund is a major shareholder of GENinCode UK Ltd.?
                  Currently, no hedge funds are holding shares in GB:GENI
                  ---

                  Company Description

                  GENinCode UK Ltd.

                  GENinCode PLC is engaged in the risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Synairgen
                  Venture Life
                  Kooth
                  Trellus Health PLC
                  Iconic Labs plc
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis